×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EWTX – edgewise therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EWTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/8
10:34 am
ewtx
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) had its price target raised by analysts at Wedbush from $44.00 to $45.00. They now have an "outperform" rating on the stock.
Low
Report
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) had its price target raised by analysts at Wedbush from $44.00 to $45.00. They now have an "outperform" rating on the stock.
11/7
08:00 am
ewtx
Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Medium
Report
Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
10/11
08:41 am
ewtx
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) had its price target raised by analysts at Piper Sandler from $48.00 to $51.00. They now have an "overweight" rating on the stock.
Medium
Report
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) had its price target raised by analysts at Piper Sandler from $48.00 to $51.00. They now have an "overweight" rating on the stock.
10/1
08:00 am
ewtx
Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society
Medium
Report
Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society
9/20
05:28 am
ewtx
Edgewise's EDG-7500 shows benefit in two obstructive HCM trials [Yahoo! Finance]
Medium
Report
Edgewise's EDG-7500 shows benefit in two obstructive HCM trials [Yahoo! Finance]
9/19
02:03 pm
ewtx
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) had its price target raised by analysts at Truist Financial Co. from $25.00 to $33.00. They now have a "buy" rating on the stock.
Low
Report
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) had its price target raised by analysts at Truist Financial Co. from $25.00 to $33.00. They now have a "buy" rating on the stock.
9/19
01:15 pm
ewtx
Why Edgewise Therapeutics Stock Is Up 50% on Thursday [Yahoo! Finance]
Medium
Report
Why Edgewise Therapeutics Stock Is Up 50% on Thursday [Yahoo! Finance]
9/19
07:00 am
ewtx
Edgewise Therapeutics Announces Positive Top-Line Data from Phase 1 Trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM)
High
Report
Edgewise Therapeutics Announces Positive Top-Line Data from Phase 1 Trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM)
Date
Time
Symbol
Company Name
Action
%Chg
8/8/2024
08:00 am
ewtx
edgewise therapeutics, inc.
BEAT
Report
5.9%
edgewise therapeutics, inc.
5/9/2024
08:00 am
ewtx
edgewise therapeutics, inc.
BEAT
Report
-6.1%
edgewise therapeutics, inc.
2/22/2024
08:00 am
ewtx
edgewise therapeutics, inc.
MISS
Report
-3.4%
edgewise therapeutics, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
06:22 pm
ewtx
Form SC 13G/A Edgewise Therapeutics, Filed by: EcoR1 Capital, LLC
Medium
Report
Form SC 13G/A Edgewise Therapeutics, Filed by: EcoR1 Capital, LLC
11/14
04:32 pm
ewtx
Form SC 13G/A Edgewise Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
Medium
Report
Form SC 13G/A Edgewise Therapeutics, Filed by: VIKING GLOBAL INVESTORS LP
11/14
04:15 pm
ewtx
Form SC 13G Edgewise Therapeutics, Filed by: BAKER BROS. ADVISORS LP
Medium
Report
Form SC 13G Edgewise Therapeutics, Filed by: BAKER BROS. ADVISORS LP
11/14
08:59 am
ewtx
Form SC 13G/A Edgewise Therapeutics, Filed by: Flynn James E
Medium
Report
Form SC 13G/A Edgewise Therapeutics, Filed by: Flynn James E
11/12
05:23 pm
ewtx
Form SC 13D/A Edgewise Therapeutics, Filed by: ORBIMED ADVISORS LLC
Medium
Report
Form SC 13D/A Edgewise Therapeutics, Filed by: ORBIMED ADVISORS LLC
11/12
09:55 am
ewtx
Form SC 13G/A Edgewise Therapeutics, Filed by: FMR LLC
Low
Report
Form SC 13G/A Edgewise Therapeutics, Filed by: FMR LLC
11/8
02:20 pm
ewtx
Form SC 13G Edgewise Therapeutics, Filed by: BlackRock, Inc.
Low
Report
Form SC 13G Edgewise Therapeutics, Filed by: BlackRock, Inc.
11/7
08:54 am
ewtx
Form S-8 Edgewise Therapeutics,
High
Report
Form S-8 Edgewise Therapeutics,
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: